蛋白酶激活受体-1对手对结肠炎相关癌症发生的治疗作用
Xiaodong Li1, Lin-Hai Kurahara1, Zhixin Zhao2
1Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Cellular and molecular gastroenterology and hepatology
|April 13, 2024
概括
在小鼠中,PAR1抗作用有效地治疗结肠炎相关的癌变,通过减轻炎症和改变肠道微生物群. 这表明一种新的治疗策略,用于炎症性肠道疾病和癌症.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 炎症性肠病 (IBD) 增加了癌症的风险.
- 蛋白酶激活受体1 (PAR1) 和蛋白酶在IBD中被上调.
- 研究了PAR1抗对结肠炎相关癌症发生的治疗效应.
研究的目的:
- 研究PAR1抗对大肠炎相关癌症发生的治疗作用.
- 探索PAR1抗对肠道微生物群的影响.
- 阐明肠道肌纤维细胞中PAR1抗的细胞机制.
主要方法:
- 通过使用氧甲 (AOM) 和硫酸 (DSS) 诱导了一种结肠炎相关的致癌小鼠模型.
- PAR1抗剂E5555是通过长期和短期协议进行的.
- 使用元基因组测序分析了肠道微生物群;肠道肌纤维细胞和Caco-2细胞被用于机械研究.
主要成果:
- 在AOM/DSS模型中,E5555治疗缓解了体重减轻,腹,瘤发育,炎症和纤维化.
- PAR1对抗改变了肠道微生物群的组成,并减少了炎症性细胞因子的产生.
- E5555抑制了肠道肌纤维细胞中的血栓激素和IL6诱导的信号通路.
结论:
- PAR1对抗性显示出结肠炎相关癌症发生的治疗潜力.
- PAR1抗可能代表炎症性肠病和相关癌症的新型治疗策略.
- 在这个模型中,肠道微生物群调节是PAR1对抗的一个关键效应.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
249
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
249


